Hedgehog Signaling Is Useful as a Novel Molecular Marker for Predicting Relapse and Resistance During Chronic Myeloid Leukemia Treatment

被引：0
|
作者：
Cea, Michele
Cagnetta, Antonia [1 ]
Cirmena, Gabriella
Garuti, Anna
Rocco, Ilaria
Palermo, Claudia
Pierri, Ivana [2 ]
Gobbi, Marco [3 ]
Ballestrero, Alberto [4 ]
Nencioni, Alessio
Patrone, Franco [4 ]
Carella, Angelo Michele [5 ]
机构：
[1] Univ Genoa, Dept Hematol, Genoa, Italy
[2] Univ Genoa, Chair Hematol, Genoa, Italy
[3] Univ Genoa, Chair Haematol, Genoa, Italy
[4] Univ Genoa, Chair Internal Med, Genoa, Italy
[5] Osped San Martino Genova, Genoa, Italy
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：521 / 521
页数：1
相关论文
共 50 条
  • [31] Hydroxyurea treatment for chronic myeloid leukemia during pregnancy
    Celiloglu, M
    Altunyurt, S
    Undar, B
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2000, 79 (09) : 803 - 804
  • [32] Treatment of molecular relapse in patients with acute myeloid leukemia using clofarabine monotherapy
    Racil, Zdenek
    Toskova, Martina
    Dvorakova, Dana
    Jeziskova, Ivana
    Razga, Filip
    Buresova, Lucie
    Timilsina, Shira
    Mayer, Jiri
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (02) : 211 - 213
  • [33] Treatment selection after imatinib resistance in chronic myeloid leukemia
    Elias Jabbour
    Jorge Cortes
    Hagop Kantarjian
    Targeted Oncology, 2009, 4 : 3 - 10
  • [34] Treatment selection after imatinib resistance in chronic myeloid leukemia
    Jabbour, Elias
    Cortes, Jorge
    Kantarjian, Hagop
    TARGETED ONCOLOGY, 2009, 4 (01) : 3 - 10
  • [35] Predicting relapse prior to transplantation in chronic myeloid leukemia by integrating expert knowledge and expression data
    Yeung, K. Y.
    Gooley, T. A.
    Zhang, A.
    Raftery, A. E.
    Radich, J. P.
    Oehler, V. G.
    BIOINFORMATICS, 2012, 28 (06) : 823 - 830
  • [36] Molecular resistance to imatinib in chronic myeloid leukemia. From the Italian Cooperative Study Group on chronic myeloid leukemia.
    Martinelli, G
    Soverini, S
    Rosti, G
    Bassi, S
    Amabile, M
    Trabacchi, E
    Giannini, B
    Cilloni, D
    Izzo, B
    de Vivo, A
    Testoni, N
    Cambrin, GR
    Bonifazi, F
    Luatti, S
    Gottardi, E
    Alberti, D
    Pane, F
    Salvatore, F
    Saglio, G
    Baccarani, M
    BLOOD, 2003, 102 (11) : 312B - 312B
  • [37] Treatment and molecular monitoring update in chronic myeloid leukemia management
    Sorel, Nathalie
    Cayssials, Emilie
    Brizard, Francoise
    Chomel, Jean-Claude
    ANNALES DE BIOLOGIE CLINIQUE, 2017, 75 (02) : 129 - 145
  • [38] Molecular Pathogenesis and Treatment Strategies of Chronic Myeloid Leukemia (CML)
    Khalid, Rabia
    Riasat, Sana
    SUDAN JOURNAL OF MEDICAL SCIENCES, 2023, 18 (04): : 525 - 538
  • [39] Molecular prediction of chronic myeloid leukemia risk and resistance to imatinib.
    Jankovic, Radmila
    Krivokuca, Ana
    Boljevic, Ivana
    Radulovic, Sinisa
    Cavic, Milena
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [40] Molecular mechanisms of resistance to STI571 in chronic myeloid leukemia
    Gorre, ME
    Sawyers, CL
    CURRENT OPINION IN HEMATOLOGY, 2002, 9 (04) : 303 - 307
12345